Zheng Quan Shi Bao Wang·2025-06-09 11:43Group 1: Innovation Drug Sector - The innovation drug sector in A-shares has seen a significant surge, with over 4,100 stocks closing in the green and the Shanghai Composite Index nearing the 3,400-point mark [1] - Notable stocks such as Changshan Pharmaceutical, Haichen Pharmaceutical, and Shutaishen achieved "20cm" limit-up, while others like Lianhua Technology and Zhongsheng Pharmaceutical recorded "10cm" limit-up [1] - According to statistics, 11 innovation drug concept stocks have seen maximum increases of over 200% compared to their one-year lows, including Hotgen Biotech and Shutaishen [1] Group 2: Central Huijin's Financial Expansion - The China Securities Regulatory Commission has approved Central Huijin Investment Co., Ltd. to become the actual controller of eight companies, marking a significant expansion of its financial footprint [4] - Central Huijin is a state-owned company established in December 2003, responsible for equity investments in key state-owned financial enterprises [5] - Since April, Central Huijin has been recognized as a "stabilization fund," boosting market confidence amid increased volatility in the domestic market [5] Group 3: Central Huijin's Stock Holdings - As of the end of Q1 this year, Central Huijin has invested in 152 stocks, with a total holding market value of 3.02 trillion yuan [6] - The largest holding is in China Bank, valued at 1.07 trillion yuan, followed by Industrial and Commercial Bank and Agricultural Bank [6][7] - Central Huijin's preference for large-cap stocks is evident, with an average market value of 1.315 billion yuan for its holdings [8] Group 4: Performance and Characteristics of Central Huijin's Holdings - In Q1, 89.47% of Central Huijin's holdings were profitable, with over 60% showing year-on-year net profit growth, significantly higher than the overall A-share market [10] - The average dividend yield for Central Huijin's holdings is 2.5%, with over 70% yielding above 1% [11] - The overall price-to-earnings ratio of Central Huijin's holdings is relatively low, with 67.76% having a rolling P/E ratio below 30 [11] Group 5: Long-term Investment Strategy - Central Huijin has a long-term investment strategy, with 135 stocks held for over 20 quarters, representing nearly 90% of its portfolio [12] - The longest-held stock is China Construction Bank, with a holding period of 67 quarters [12] - Notable long-term holdings also include leading companies in emerging industries such as BYD and Hikvision [12] Group 6: Market Performance of Long-term Holdings - Among the 135 stocks held for over 20 quarters, 14 have doubled in value since 2021, with China Shenhua leading at a 199.29% increase [13][14] - The performance of these long-term holdings reflects Central Huijin's commitment to stable and profitable investments [13]